Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

Ultimaster™ Tansei™ - Drug eluting stent

Read more Read less

Delivery system specifications

​Guidewire compatibility​0.014’’ (0.36 mm)
​Low compliant balloon​Material Nylon 12
​Nominal pressure​9 atm
​Rated burst pressure​16 atm - 2.25 to 3.0 mm
​14 atm - 3.5 to 4.0 mm
​Entry profile​0.018’’ (0.45 mm)
​Crossing profile​0.044’’ (1.12 mm) for 3.0 mm
​ShaftMax size - 2.7 Fr (0.89 mm)​
​Min size - 1.9 Fr (0.64 mm)
​Coating​Hydrophilic - Distal shaft
​Minimum Guide catheter​5 Fr (0.056’’/1.42 mm)
​Usable length​144 cm

Stent specifications

​Stent design​Open cell
​Stent material​Cobalt Chromium L605
​Strut thickness​80 μm
​Cell size (for 3 mm stent)​4.57 mm²
​Drug dose​3.9 μg/mm stent length
​Polymer​Poly (DL-lactide-co‑caprolactone)
Coating​Abluminal & gradient
​Polymer degradation time and drug release​3-4 months

​Length (mm)
Diameter (mm)​ ​ ​ ​ ​ ​
​09 mm
​12 mmDE-RQ2212KSM
​15 mm​DE-RQ2215KSMDE-RQ2515KSM
​18 mm​DE-RQ2218KSM​DE-RQ2518KSM
​21 mm​DE-RQ2221KSMDE-RQ2521KSM









Ultimaster™ Tansei™ IFU Product Info/Ultimaster™ Tansei™ IFU.PDFUltimaster™ Tansei™ IFU15/04/2018 22:00:00{199E72F2-0235-4625-B97B-1F2DB068DC30}HayabusaArticleDocument77054ba1-476b-4af3-b914-9a049e0b9ba8

Based on data from e-Ultimaster clinical study, data on file Terumo Europe

PCI – Percutaneous Coronary Intervention

1 Internal report ISCD-523-37-19 - Report-eUM-Interim analysis

2 Bench test ISCD-523-31-18 performed by, and on file at Terumo Corporation

3 ULTIMASTER Clinical Program

4 Chevalier et al. Circ Cardiovasc Interv 2017;10:doi:10.1161/CIRCINTERVENTIONS.116.004801

Did you not find the product you were looking for?